STOCKHOLM – March 29, 2017 – ContextVision, a medical technology company specializing in image analysis and artificial intelligence, has started a collaboration and signed an agreement with ALABplus, one of Poland’s largest provider of pathology services, to secure access to a significant amount of data for deep learning product development within digital pathology.
“The present contract is extremely valuable for ContextVision as we secure access to as much material as we need, which will boost the product development phase“, said Anita Tollstadius, CEO.
In 2015, ContextVision made the strategic decision to enter a new, rapidly growing market, digital pathology, in order to open up for a significant company growth. The company decided to become a major supplier of image analysis products and is heading a three-year Eurostar sponsored research program. In this project, the company is using … Read More »Read More...
Stockholm, Sweden – March 14, 2017 – ContextVision, a leading provider of medical imaging software specializing in image analysis and artificial intelligence, received a patent approval on a new technology for the visualization of the skeleton from 3D ultrasound. The patent was filed in 2014.
The technology is based on a visualization software and improves the potential for early discovery of skeletal irregularities in unborn babies.
This offers a unique product feature named SkeletalView which is integrated into ContextVision’s groundbreaking 3D rendering product, REALiCE, which is commercially available.
SkeletalView enables the clinicians to obtain a more accurate view of the fetal skeleton during pregnancy. This product feature helps the clinicians examine the fetus for spontaneous fractures and skeletal malformations. It also facilitates the measurement of bone structures.
“Our new visualization product REALiCE has received … Read More »Read More...
On the 6th of March, the Norwegian business newspaper Finansavisen published an article about ContextVision. Find the article here:Read More...
Train & Treat. Cognitive Machines For MedicineRead More...
Please follow the link to find the latest results analysis from Norne:
2017 March 2
For previous analysis, visit Analyst Coverage
On February 27th 2017, ContextVision held a company presentation at Norne in Oslo.
CEO Anita Tollstadius gave an update of the company’s development and shared the company’s future direction.
Please find a PDF-version of the presentation here.
For inquires please contact CEO Anita Tollstadius; firstname.lastname@example.orgRead More...
Artikel om ContextVision i Investeringstipset, 23e februari 2017.
Följ länken nedan för att komma till artikeln:
CONTEXTVISION SEES RECORD-BREAKING FOURTH QUARTER SALES
STOCKHOLM, Sweden – Feb. 23, 2017 – ContextVision, a world leading provider of medical image processing software, saw record-breaking quarterly sales and is on track to be a leader in image analysis for digital pathology.
Q4 2016 Performance
Sales for the fourth quarter reached a record of 24.9 MSEK. Annual revenue reached 81.9 MSEK, which is the highest annual sales for the second year running. The operating profit in the quarter was 2.9 MSEK (1.1 MSEK) and the operating margin was 11.8 percent (5.9 percent), targeting future growth by supporting research efforts. “We are very pleased that we are able to generate profit whilst investing significantly into research. The research program is developing very well, positioning the company to become a leading medical technology company using artificial intelligence,” said ContextVision’s CEO, Anita Tollstadius. ContextVision saw strong … Read More »Read More...
We are pleased to invite you to a presentation of Contextvision AB and its Q4 and full-year 2016 figures at the offices of Norne Securities AS (Oslo Office), Haakon VIIs gt. 9, Oslo;
Monday, February27th at 12.00
Lunch will be served
We would also like to take the opportunity to give our shareholders an update on some of the important steps towards new business opportunities and future growth. To this meeting we will bring our CFO Ann-Charlotte Linderoth.
You are most welcome.
CEO, ContextVision AB
Please, announce your participation beforehand to
FINANCIAL YEAR 2016
Quarterly Report – Q4 – 23.02.2017
FINANCIAL YEAR 2017
Quarterly Report – Q1 – 27.04.2017
Quarterly Report – Q2 – 17.08.2017
Quarterly Report – Q3 – 26.10.2017
Quarterly Report – Q4 – 22.02.2018
Annual General Meeting – 10.05.2017
For further questions please contact CFO Ann-Charlotte Linderoth; email@example.com
This information is published pursuant to the requirements set out in section 4.5 of the Continuing obligations of stock exchange listed companies.
Download pdf »Read More...